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INTRODUCTION
Cell cycle progression is controlled by the expression and activation of various cyclin/ cyclin-dependent kinase (CDK) complexes. 1,2 D and E-type cyclins govern the rate of progression of mammalian cells through the first gap phase (G 1 ) of the cell cycle and enforce the commitment of cells to replicate their chromosomal DNA. 1 In general, D-type cyclins, expressed in response to growth promoting signals, are induced earlier in G 1 than cyclin E1 and form complexes with CDK4/6. 3 Cyclin E1 is synthesized in late G 1 and associates with CDK2. Cyclin D-CDK4 and cyclin D-CDK6 phosphorylate and inactivate the retinoblastoma protein (pRb) and related proteins p107, p130. 4, 5 Cyclin E-CDK2 complexes participate in sustained inactivation of pRb and release of E2F-dependent transcription. In addition, through the phosphorylation of other substrates, they play other critical roles 6 in centrosome duplication, 7 replication origin firing, 8, 9 and histone expression. 10 The second messenger cAMP plays multiple roles in cell proliferation control and progression through the different cell cycle phases. 11 In different cell types, cAMP exerts different positive or negative roles in G 1 phase progression by diversely regulating both the expression and activity of D-type cyclin-CDK complexes. 12, 13 cAMP could also affect initiation or elongation of DNA replication. 14, 15, 16 Moreover, cAMP ubiquitously appears to prevent mitosis onset 11, 17, 18 and progression, 19 and could play a role in chromosome condensation. 20 cAMP mainly acts in mammalian cells by binding to its receptor proteins, cAMP-dependent protein kinase (PKA) regulatory (RI or RII) subunits, 21 which releases catalytic (C) subunits. Although PKAs have a broad substrate specificity, one aspect of their action is the ability to selectively phosphorylate individual substrates in response to distinct hormonal stimuli. This selectivity is mediated for PKAII by its interaction with a family of functionally related A-kinase anchoring proteins (AKAPs), 22 which sequester the PKA to specific subcellular locations (reviewed in refs. 23 and 24) .
AKAP95 tethers PKAII to the nucleus. Its sequence comprises a nuclear matrix targeting site, a bipartite nuclear localization signal (NLS), two zinc fingers, and a RII binding domain. 25, 26, 27 AKAP95 was reported to play an essential role in chromatin condensation during mitosis through anchoring of PKA signaling complex and the recruitment of components of condensin complex onto chromatin. 20, 28, 29 The same group also suggested that AKAP95 could play a role in DNA replication by providing a chromatin scaffold for minichromosome maintenance protein 2 (MCM2), a component of the hexameric MCM2-7 DNA helicase prereplication complex (preRC). 15 We have previously demonstrated the interaction between AKAP95 and the three D-type cyclins in different mammalian cell types. 30 Here we present evidence for the interaction of cyclin E1 with AKAP95. This interaction, similar to AKAP95-cyclin D interaction, is displaced by the catalytic partner of cyclin E1, CDK2. We also describe that
RESULTS
AKAP95 interacts with cyclin E1 in intact cells. In a previous work, we have demonstrated the interaction of AKAP95 with the three D-type cyclins. 30 To investigate whether AKAP95 can bind to other cyclins, coimmunoprecipitation experiments were performed in transfected CHO cells. His-tagged full-length dog AKAP95 protein was coexpressed with human full-length cyclin E1 (Fig. 1,  WCE) . AKAP95 was then immunoprecipitated with polyclonal anti-AKAP95 antibody. Using anti-cyclin E1 immunoblot analysis, we showed that cyclin E1 coimmunoprecipitated with AKAP95 specifically from cells transfected with both cyclin E1 and AKAP95 (Fig. 1 , IP: α-AKAP95).
AKAP95 and CDKs compete for the interaction with G 1 /S cyclins. We previously reported that AKAP95 was not present in cyclin D3 immunoprecipitates when CDK4 was overexpressed in the cells. 30 We completed this observation by immunoprecipitating AKAP95 from CHO cells either untransfected, or transfected with AKAP95 alone, AKAP95 and cyclin D3, or AKAP95, cyclin D3 and CDK4 ( Fig. 2A) . Cyclin D3 coimmunoprecipitated with AKAP95 only when CDK4 was not overexpressed ( Fig. 2A , IP: α-AKAP95). These results indicate that CDK4 competes with AKAP95 for binding to cyclin D3, thus displacing AKAP95. Similarly, CDK2 expression prevented binding of cyclin E to AKAP95 (Fig. 2B) . Same results were obtained in CHO cells and JP19 cells that were stimulated by forskolin and TSH, respectively, to increase their cellular cAMP levels (data not shown). G 1 /S cyclins interact with RIIα of PKA via AKAP95. As AKAP95 localizes PKA in the nucleus by binding to its RIIα subunit, 26 we next assessed if cyclin D3 may associate with RIIα subunit of PKA. Cyclin D3 and RIIα (Fig. 3A) , or cyclin D3, RIIα and AKAP95 were ectopically coexpressed in transfected CHO cells (Fig. 3A, WCE), and immunoprecipitations of RIIα protein were performed via its Myc tag (Fig. 3A, IP) . Cyclin D3 coimmunoprecipitated with RIIα, but only when AKAP95 was coexpressed. A similar experiment was performed with cyclin E1, and RIIα was coimmunoprecipitated with cyclin E1 only when AKAP95 was coexpressed (Fig. 3B) . These results clearly imply that AKAP95 is a bridging adaptor between G 1 /S cyclins and PKAIIα regulatory subunit.
cAMP does not regulate the assembly of Cyclin D3-AKAP95. We next wanted to assess whether PKA activation could influence the association between AKAP95 and G 1 /S cyclins. Coimmunoprecipitation of cyclin D3-AKAP95 complex was performed in CHO cells stably transfected with TSH receptor (JP19) 32 with and without TSH stimulation (Fig. 4 ). AKAP95 coimmunoprecipitated with cyclin D3 in JP19 cells whether they were stimulated with TSH (lane 8) or not (lane 4). Of note, AKAP95 was weakly coimmunopreciptated by the cyclin D3 antibody in cells solely transfected by AKAP95 (lanes 2 and 6). This could be due to a low endogenous expression of cyclin D3 in these cells. Cyclin D3-AKAP95 association was thus not compromised upon PKA stimulation. Similar results were obtained with cyclin E (data not shown).
Determination of PKA activity associated with Cyclin D3. In order to test whether the association of PKA with cyclin D3 via AKAP95 could involve the catalytic (C) subunit, PKA activity was assayed in cyclin D3 immunoprecipitates and in several control conditions, as explained in Material and methods. As shown in Figure 5 , a strong PKA activity was observed in cell extracts transfected with PKA and cyclin D3, as well as in immunoprecipitations of RIIα performed with the Myc antibody [IP: α-Myc (RIIα), lanes 1-3]. Diminution of radioactive signal in lane 3 was likely due to diminished levels of single DNA and/or reduced transfection efficiency in the quadruple transfections. No PKA activity was detected in cyclin D3 immunoprecipitates (lanes 4 and 5), as in control immunoprecipitation using Ig G (lane 7). However, this result could not lead us to definitely conclude that no PKA activity was associated with cyclin D3. Indeed, the AKAP95-bound PKA activity (IP: α-AKAP95, lane 6) represented a rather small fraction of total PKAIIα activity. As only a fraction of this AKAP95 was likely to be bound to cyclin D3, the PKA activity associated with cyclin D3 via AKAP95 might well be below the detection limit of the PKA assay.
DISCUSSION
AKAPs are scaffolding proteins that specifically anchor and localize PKA to specific subcellular structures. 23 In addition to directing the action of PKA, AKAPs engage other signaling molecules as well. 24 These complexes are assembled in dynamic response to upstream signals and are often tethered close to specific substrate proteins. The present study is the first to suggest that a peculiar AKAP, AKAP95, could allow the physical interaction between a PKA subunit and several cyclins that regulate the cell cycle in G 1 phase and at the G 1 /S transition. Indeed, we have previously identified AKAP95 as a protein partner of the three D-type cyclins. 30 We now demonstrate that AKAP95 similarly interacts with cyclin E1, suggesting a wider importance of these new interactions for cell cycle progression. Moreover, we show that AKAP95 serves as a bridging adaptor for the association of the RIIα subunit of PKA with cyclins D3 and E1. Recently, nuclear AKAP95 was reported to be critical for DNA replication by providing a chromatin anchor for MCM2. AKAP95-RIIα association was described as dispensable for this process, although PKI (PKA inhibitor) reduced the efficiency of replication initiation. 15 Besides their well-established role in the inactivation of Rb proteins and resulting induction of E2F-dependent gene transcription, D-type and E-type cyclins have recently been found to play distinct and subsequent roles in the assembly of the prereplication complex and licensing of DNA replication. Upon mitogenic stimulation, D-type cyclins are induced and assembled with CDK4/6 before the appearance of cyclin E. By interacting with MCM7 and MCM3, D-type cyclin-CDK4, but not cyclin E-CDK2, catalyzes the disruption of an inhibitory pRb-MCM7 interaction, thus allowing the release of pRb from chromatin-bound protein complexes. 33, 34 In a process that critically depends on the activities of both cyclin E and the licensing factor Cdc6, this would facilitate the loading of MCM proteins, including MCM2, 35 onto replication origins during G 0 → S phase transition. 9, 36, 37 In this process, cyclin E-CDK2 would promote DNA replication origin licensing by phosphorylating Cdc6, thus preventing its degradation by the APC/cyclosome complex. 38, 39 Within this conceptual framework, our present observations and those of Eide et al, 15 showing that D-type cyclins and cyclin E1 can interact with AKAP95, which itself provides the required chromatin anchorage of MCM2, 15 would not be fortuitous. They would suggest the following hypothetic model. Endogenous AKAP95 and cyclin D1 colocalize on chromatin in G 1 phase of the cell cycle (data not shown). 15, 33 We have observed that the formation of the cyclin D-CDK4 complex could displace the cyclin D-AKAP95 interaction (Fig. 2) . Upon mitogenic stimulation, this would allow both the mobilization of cyclin D-CDK4 in the close vicinity of its chromatin-bound substrates, such as pRb to release the inhibitory MCM7 interaction, 33, 34 and the cyclin E-AKAP95 interaction. In . PKA activity in cell lysates and immunoprecipitates was determined by in vitro kinase assay, as described in Materials and methods. The biotinylated substrate was allowed to bind to SAM2 Biotin Capture Membrane, and its phosphorylation was detected by autoradiography.
G1/S Cyclins Interact with PKA via AKAP95 turn, this interaction would allow the mobilization of cyclin E-CDK2 at the replication origins, where, along or in cooperation with the Dbf4-Cdc7 kinase, 40 it could phosphorylate and potentially regulate replication complex proteins, including MCM2 itself and MCM4, 41, 42 Cdc6 38, 39 or even Cdc7. 43 This model would be fully consistent with the requirement of AKAP95 for DNA replication observed in vitro. 15 The cyclin-AKAP95 interaction would thus ensure a spatiotemporal restriction of CDK activity in the close proximity of the firing replication origins.
The potential implication of PKA in such a model is unclear. At least a basal PKA activity has been reported as required for the initiation of DNA replication. 16, 15 In the present study, we did observe an interaction between RIIα and cyclin D3 or cyclin E1, depending on the presence of AKAP95. This implies an association of AKAP95 with RIIα in interphase cells, which is at variance with their restricted interaction found only in mitosis cells. 20, 44 However, the interaction of PKA with AKAP95 has also been investigated in interphase cells by others. 26, 45 As the RIIα-AKAP95 interaction is claimed to depend on Thr54 phosphorylation of RIIα by CDK1, 44 further studies should investigate whether a fraction of RIIα could not be phosphorylated at Thr54 at other cell cycle phases by other CDK complexes, including CDK4 and CDK2. Although cAMP increased the phosphorylation of AKAP95 possibly through the RIIα-AKAP95 interaction (data not shown), cAMP did not affect the RIIα-AKAP95-cyclin D/E1 association. In this study, we have been unable to detect a PKA activity, and thus the C subunit, in association with cyclin D3, most likely because AKAP95-bound PKA represented itself only a rather small fraction of total PKAII activity. A yet to define role in cell cycle progression and DNA replication of a thin fraction of PKAII, associated with cyclins on chromatin through AKAP95 binding, thus could not be excluded. Interestingly, PKAI might also play a role in the initiation of replication by CDK2. During the preparation of this manuscript, cyclin E-CDK2 was reported to bind and phosphorylate PKA RIα, to release the replication factor RFC40. 46 
